Interventional Cardiology Devices Market
According to Intent Market Research, the Interventional Cardiology Devices Market is expected to grow from USD 20.6 Billion in 2024-e at a CAGR of 7.3% to touch USD 31.5 Billion by 2030. The Interventional Cardiology Devices Market is dominated by key players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, and Biosensors International Group.